BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 992546)

  • 21. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma.
    Ohashi A; Ishizaki M; Kawana S; Fukuda Y
    Pathol Int; 2004 Aug; 54(8):585-94. PubMed ID: 15260849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Keratoacanthoma: two cases with intravascular spread].
    Gottfarstein-Maruani A; Michenet P; Kerdraon R; Bonneau C; Heitzmann A; Estève E; Rémy RC
    Ann Pathol; 2003 Oct; 23(5):438-42. PubMed ID: 14752388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nosologic situation of keratoacanthoma centrifugum].
    Miedziński F; Dratwiński Z; Brzozowski J; Sarankiewicz B
    Hautarzt; 1973 Mar; 24(3):120-3. PubMed ID: 4713263
    [No Abstract]   [Full Text] [Related]  

  • 25. Keratoacanthoma vs. squamous cell carcinoma in contrast with keratoacanthoma is squamous cell carcinoma.
    Hurt MA
    J Cutan Pathol; 2004 Mar; 31(3):291-2; author reply 292-3. PubMed ID: 14984586
    [No Abstract]   [Full Text] [Related]  

  • 26. [Subungual keratoacanthoma].
    Bräuninger W; Hoede N
    Hautarzt; 1986 May; 37(5):270-3. PubMed ID: 3733446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA; Ross JS; Sheehan CE; Carlson JA
    Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Actinic keratoacanthoma.
    Reed RJ
    Arch Dermatol; 1972 Dec; 106(6):858-64. PubMed ID: 4639249
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraepithelial elastic fibers and intracytoplasmic glycogen: diagnostic aids in differentiating keratoacanthoma from squamous cell carcinoma.
    King DF; Barr RJ
    J Cutan Pathol; 1980 Jun; 7(3):140-8. PubMed ID: 7440813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB; Lee YS
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues.
    Kluger N; Plantier F
    J Am Acad Dermatol; 2007 Nov; 57(5):901-2. PubMed ID: 17939943
    [No Abstract]   [Full Text] [Related]  

  • 34. Lectin-binding sites in squamous cell carcinomas and keratoacanthomas.
    Ramírez-Bosca A; Reano A; Valcuende-Cavero F; Thivolet J; Castells-Rodellas A
    Acta Derm Venereol; 1988; 68(6):480-5. PubMed ID: 2467485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidermoid carcinoma or keratoacanthoma?].
    Estruch R; Aguilera MT; Cardellach F; Palou J
    Med Clin (Barc); 1986 Oct; 87(11):477. PubMed ID: 3784650
    [No Abstract]   [Full Text] [Related]  

  • 36. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma.
    Randall MB; Geisinger KR; Kute TE; Buss DH; Prichard RW
    Am J Clin Pathol; 1990 Feb; 93(2):259-62. PubMed ID: 2301286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitatively evaluated ultrastructural findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma.
    Miracco C; De Santi MM; Lio R; Biagioli M; Tosi P; Luzi P
    J Submicrosc Cytol Pathol; 1992 Jul; 24(3):315-21. PubMed ID: 1394087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
    Tran TA; Ross JS; Boehm JR; Carlson JA
    J Cutan Pathol; 1999 Sep; 26(8):391-7. PubMed ID: 10551411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas.
    Ho T; Horn T; Finzi E
    Arch Dermatol; 1991 Aug; 127(8):1167-71. PubMed ID: 1863074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Keratoacanthoma and carcinoma].
    Gründer B; Hundeiker M
    Dermatol Monatsschr; 1973 Feb; 159(2):122-33. PubMed ID: 4701746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.